Advanced search
Publication Cover
Cancer Investigation Volume 16, 1998 - Issue 6
Submit an article Journal homepage
175
Views
50
CrossRef citations to date
0
Altmetric
Original Article

A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression

Roy A. Beveridge Fairfax Hematology-Oncology Associates, Inc. Annandale, Virginia
,
John A. Miller Fairfax Hematology-Oncology Associates, Inc. Annandale, Virginia
,
Arthur N. Kales Fairfax Hematology-Oncology Associates, Inc. Annandale, Virginia
,
Richard A. Binder Fairfax Hematology-Oncology Associates, Inc. Annandale, Virginia
,
Nicholas J. Robert Fairfax Hematology-Oncology Associates, Inc. Annandale, Virginia
,
Jimmie H. Harvey Birmingham, Alabama
,
Kevin Windsor Birmingham, Alabama
,
Ira Gore Bruno Cancer Center Birmingham, Alabama
,
James Cantrell Bruno Cancer Center Birmingham, Alabama
,
Keith A. Thompson Mongtomery Cancer Center Montgomery, Alabama
,
William R. Taylor Mongtomery Cancer Center Montgomery, Alabama
,
Harry M. Barnes Mongtomery Cancer Center Montgomery, Alabama
,
Steven A. Schiff Alpine Hematology-Oncology Reno, Nevada
,
John A. Shields Alpine Hematology-Oncology Reno, Nevada
,
Richard J. Cambareri Arlington, Virginia
,
Thomas P. Butler Arlington, Virginia
,
Robert J. Meister Arlington, Virginia
,
John M. Feigert Arlington, Virginia
,
Michael J. Norgard The Cancer Center Montgomery, Alabama
,
Manoel A. Moraes The Cancer Center Montgomery, Alabama
,
William W. Helvie The Cancer Center Montgomery, Alabama
,
Gregory A. Patton The Cancer Center Montgomery, Alabama
,
Larry J. Mundy The Cancer Center Montgomery, Alabama
,
David Henry Philadelphia, Pennsylvania
,
Bernard Mason Philadelphia, Pennsylvania
,
Arthur Staddon Philadelphia, Pennsylvania
,
Patricia Ford Philadelphia, Pennsylvania
,
Daniel Katcher Woodbridge, Virginia
,
William Houck Shenandoah Oncology Associates, Inc. Winchester, Virginia
,
William B. Major Shenandoah Oncology Associates, Inc. Winchester, Virginia
,
Nicholas W. Gemma Shenandoah Oncology Associates, Inc. Winchester, Virginia
,
Gary Kay Elk Grove Village, Illinois
,
Edwin Priest Elk Grove Village, Illinois
,
Paul Sowroy Elk Grove Village, Illinois
,
Bruce Bank Elk Grove Village, Illinois
,
Steven Leibach Elk Grove Village, Illinois
,
Herbert Reisel Elk Grove Village, Illinois
,
Gary Grad Elk Grove Village, Illinois
,
Robert D. Warren Alexandria, Virginia
,
Winston M. Ueno Alexandria, Virginia
,
Lee F. Smith Alexandria, Virginia
,
Robert F. Dobrzynski Alexandria, Virginia
&
Michael J. Sheridan Inova Institute of Research and Education Falls Church, Virginia
 show all
Pages 366-373 | Published online: 11 Jun 2009

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

H. J. Henk, L. Becker, H. Tan, J. Yu, A. Kavati, A. Naeim, R. Deeter & R. Barron. (2013) Comparative effectiveness of pegfilgrastim, filgrastim, and sargramostim prophylaxis for neutropenia-related hospitalization: two US retrospective claims analyses. Journal of Medical Economics 16:1, pages 160-168.
Read now
Şuayib Yalçin. (1999) Hematopoietic Growth Factors for Chemotherapy-Induced Neutropenia. Cancer Investigation 17:7, pages 555-555.
Read now

Articles from other publishers (48)

Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, S Jennifer Wang, Lauren K Brais, Joshua Remland, C Elizabeth Keheler, Keri M Sullivan, Thomas A Abrams, Leah H Biller, Peter C Enzinger, Nadine J McCleary, Anuj K Patel, Douglas A Rubinson, Benjamin Schlechter, Sarah Slater, Matthew B Yurgelun, James M Cleary, Kimberly Perez, Michael Dougan, Kimmie Ng, Brian M Wolpin, Harshabad Singh & Stephanie K Dougan. (2023) G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. Journal for ImmunoTherapy of Cancer 11:6, pages e006589.
Crossref
Sabrina Zippel, Nadine Dilger, Chandralekha Chatterjee, Annamarija Raic, Gerald Brenner-Weiß, Patrik Schadzek, Bastian E Rapp & Cornelia Lee-Thedieck. (2022) A parallelized, perfused 3D triculture model of leukemia for in vitro drug testing of chemotherapeutics. Biofabrication 14:3, pages 035011.
Crossref
Thomas A. Winters, Lanyn P. Taliaferro & Merriline M. Satyamitra. (2022) Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways. Radiation Research 197:5.
Crossref
Merriline M. Satyamitra, Andrea L. DiCarlo, Brynn A. Hollingsworth, Thomas A. Winters & Lanyn P. Taliaferro. (2021) Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways. Radiation Research 197:5.
Crossref
Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale & Gary H. Lyman. (2021) Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?. Frontiers in Immunology 12.
Crossref
Saeed Yousofian, Ghasem Miri-Aliabad, Azadeh Kiumarsi & Tayeb Ramim. (2021) Effectiveness of filgrastim and polyethylene glycol-filgrastim in the treatment of postchemotherapy neutropenia in children: Phase I clinical trial. Indian Journal of Medical and Paediatric Oncology 40:01, pages 101-104.
Crossref
Allison Karst & Jonathan Lister. (2018) Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion. Mental Health Clinician 8:5, pages 250-255.
Crossref
Ian Macreadie. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology 1 24 .
Joongkee Min, Jeong Hoon Kim, Kyoung Hyo Choi, Hyung Ho Yoon & Sang Ryong Jeon. (2017) Is There Additive Therapeutic Effect When GCSF Combined with Adipose-Derived Stem Cell in a Rat Model of Acute Spinal Cord Injury?. Journal of Korean Neurosurgical Society 60:4, pages 404-416.
Crossref
Yi-ju Cheng, Ran Wu, Ming-liang Cheng, Juan Du, Xi-wei Hu, Lei Yu, Xue-ke Zhao, Yu-mei Yao, Qi-zhong Long, Li-li Zhu, Juan-juan Zhu, Ni-wen Huang, Hua-juan Liu, Ya-xin Hu & Fang Wan. (2016) Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions. Oncotarget 8:19, pages 32228-32236.
Crossref
Annegret Winkler, Silke Kietz, Hagen Bahlmann, Gunel Jafarzade, Holger N. Lode & Matthias Heckmann. (2016) GM-CSF as successful salvage therapy of metamizole (dipyrone)-induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent. Clinical Case Reports 4:8, pages 816-819.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 1154 1155 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 620 626 .
Nicole Skoetz, Julia Bohlius, Andreas Engert, Ina Monsef, Oliver Blank & Jörg-Janne Vehreschild. (2015) Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane Database of Systematic Reviews 2015:12.
Crossref
Weihong Chen, David Rizzieri & Susan Drago. (2015) Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/?l. Journal of Clinical Apheresis 30:1, pages 28-31.
Crossref
Rahul Mhaskar, Otavio Augusto Camara Clark, Gary Lyman, Tobias Engel Ayer Botrel, Luciano Morganti Paladini & Benjamin Djulbegovic. (2014) Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Andrea Pennati, Jiusheng Deng & Jacques Galipeau. (2014) Maltose-Binding Protein Fusion Allows for High Level Bacterial Expression and Purification of Bioactive Mammalian Cytokine Derivatives. PLoS ONE 9:9, pages e106724.
Crossref
J.J. Vehreschild, A. Böhme, O.A. Cornely, C. Kahl, M. Karthaus, K.-A. Kreuzer, G. Maschmeyer, S. Mousset, V. Ossendorf, O. Penack, M.J.G.T. Vehreschild & J. Bohlius. (2014) Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy—evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Annals of Oncology 25:9, pages 1709-1718.
Crossref
Derek Weycker, Jennifer Malin, Rich Barron, John Edelsberg, Alex Kartashov & Gerry Oster. (2012) Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy. American Journal of Clinical Oncology 35:3, pages 267-274.
Crossref
Santosh Saraf & Howard Ozer. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF 109 149 .
Bhanu Vakkalanka & Brian K. Link. (2011) Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma. Advances in Hematology 2011, pages 1-7.
Crossref
Erin F. Nicholls, Laurence Madera & Robert E. W. Hancock. (2010) Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Annals of the New York Academy of Sciences 1213:1, pages 46-61.
Crossref
Y C Cheng, V Valero, M L Davis, M C Green, A M Gonzalez-Angulo, R L Theriault, J L Murray, G N Hortobagyi & N T Ueno. (2010) Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. British Journal of Cancer 103:9, pages 1331-1334.
Crossref
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology 355 455 .
Mark L. Heaney, Edmond L. Toy, Francis Vekeman, François Laliberté, Bree L. Dority, Daniel Perlman, Victoria Barghout & Mei Sheng Duh. (2009) Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy‐Induced neutropenia. Cancer 115:20, pages 4839-4848.
Crossref
Michael DouganGlenn Dranoff. (2009) Immune Therapy for Cancer. Annual Review of Immunology 27:1, pages 83-117.
Crossref
Julia Bohlius, Christine Herbst, Marcel Reiser, Guido Schwarzer & Andreas Engert. (2008) Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database of Systematic Reviews.
Crossref
Ian Macreadie. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Thierry Vial & Jacques Descotes. 2007. Cytokines in Human Health. Cytokines in Human Health 319 348 .
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2407 2408 .
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 1553 1558 .
Toshiki Kazama, Nancy Swanston, Donald A. Podoloff & Homer A. Macapinlac. (2005) Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. European Journal of Nuclear Medicine and Molecular Imaging 32:12, pages 1406-1411.
Crossref
Emma C Sasse, Andre D Sasse, Sílvia R Brandalise, Otavio Augusto Camara Clark & Sue Richards. (2005) Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews.
Crossref
Otavio A.C. Clark, Gary H. Lyman, Aldemar A. Castro, Luciana G.O. Clark & Benjamin Djulbegovic. (2005) Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Oncology 23:18, pages 4198-4214.
Crossref
Siu-Fun Wong & Holly O. Chan. (2005) Effects of a Formulary Change from Granulocyte Colony-Stimulating Factor to Granulocyte-Macrophage Colony-Stimulating Factor on Outcomes in Patients Treated with Myelosuppressive Chemotherapy. Pharmacotherapy 25:3, pages 372-378.
Crossref
Carrie Cappozzo. (2004) Optimal Use of Granulocyte-Colony-Stimulating Factor in Patients With Cancer Who Are at Risk for Chemotherapy-Induced Neutropenia. Oncology Nursing Forum 31:3, pages 569-576.
Crossref
Mary E. Johnston, Melissa C. Brouwers & George P. Browman. (2004) KEEPING CANCER GUIDELINES CURRENT: RESULTS OF A COMPREHENSIVE PROSPECTIVE LITERATURE MONITORING STRATEGY FOR TWENTY CLINICAL PRACTICE GUIDELINES. International Journal of Technology Assessment in Health Care 19:4, pages 646-655.
Crossref
Julia Bohlius, Marcel Reiser, Guido Schwarzer & Andreas Engert. (2003) Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review. British Journal of Haematology 122:3, pages 413-423.
Crossref
Der-Cherng Liang. (2003) The Role of Colony-Stimulating Factors and Granulocyte Transfusion in Treatment Options for Neutropenia in Children with Cancer. Pediatric Drugs 5:10, pages 673-684.
Crossref
Patricia C. Buchsel, Annette Forgey, Felicia Browning Grape & Sharon S. Hamann. (2002) Granulocyte Macrophage Colony-Stimulating Factor: Current Practice and Novel Approaches. Clinical Journal of Oncology Nursing 6:4, pages 198-205.
Crossref
Otavio Augusto Camara Clark, Gary Lyman, Aldemar A Castro, Luciana GO Clark & Benjamin Djulbegovic. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Howard OzerJames O. ArmitageCharles L. BennettJeffrey CrawfordGeorge D. DemetriPhilip A. PizzoCharles A. SchifferThomas J. SmithGeorge SomloJames C. WadeJames L. WadeIIIIIIRodger J. WinnAntoinette J. WozniakMark R. Somerfield. (2000) 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines. Journal of Clinical Oncology 18:20, pages 3558-3585.
Crossref
Roy A. Beveridge, David H. Regan, Grant Swanson & Eva Stump. (2000) Evaluation: Continued Need for Randomized Trials. Journal of Clinical Oncology 18:18, pages 3321-3322.
Crossref
Ronald J. Moleski. (2012) Comparison of G‐CSF and GM‐CSF Adverse Event Profiles in Office‐Based Practices: Preliminary Study Results. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20:7P2.
Crossref
Grant SwansonKim BergstromEva StumpTammi MiyaharaE.T. Herfindal. (2000) Growth Factor Usage Patterns and Outcomes in the Community Setting: Collection Through a Practice-Based Computerized Clinical Information System. Journal of Clinical Oncology 18:8, pages 1764-1770.
Crossref
Charles H. WeaverKevin A. SchulmanBarbara Wilson-RelyeaRobert BirchWilliam WestC. Dean Buckner. (2000) Randomized Trial of Filgrastim, Sargramostim, or Sequential Sargramostim and Filgrastim After Myelosuppressive Chemotherapy for the Harvesting of Peripheral-Blood Stem Cells. Journal of Clinical Oncology 18:1, pages 43-43.
Crossref
Thierry Vial & Jacques Descotes. 2000. 391 417 .
Henrik van Deventer & Thomas Shea. 1999. Clinical Applications of Cytokines and Growth Factors. Clinical Applications of Cytokines and Growth Factors 279 299 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.